Combination of an insulin and a GLP-1 agonist

Details for Australian Patent Application No. 2009305472 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Werner, Ulrich; Rotthauser, Barbel; Smith, Christopher James

Agent Watermark

Pub. Number AU-A-2009305472

PCT Pub. Number WO2010/043566

Priority 10 2008 051 834.4 17.10.08 DE; 10 2009 038 210.0 20.08.09 DE; 10 2008 053 048.4 24.10.08 DE

Filing date 9 October 2009

Wipo publication date 22 April 2010

International Classifications

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/043566 Priority application(s): WO2010/043566

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009305477-Process for the preparation of optically active (S)-(-)-2- (N-propylamino)-5-methoxytetraline and (S)-(-)-2- (N-propylamino)-5-hydroxytetraline compounds

2009305471-Medical device with controllably releasable antibacterial agent